Literature DB >> 9765697

[Management of the unscheduled interruption or prolongation of a radical course of radiotherapy].

M Baumann, T Herrmann.   

Abstract

Mesh：

Year:  1998        PMID： 9765697     DOI： 10.1007/bf03038634

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN： 0179-7158            Impact factor:   3.621


× No keyword cloud information.
  7 in total

1.  Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: a randomised multicentre trial. CHART Steering Committee.

Authors:  M Saunders; S Dische; A Barrett; A Harvey; D Gibson; M Parmar
Journal:  Lancet       Date:  1997-07-19       Impact factor: 79.321

2.  A modelled comparison of the effects of using different ways to compensate for missed treatment days in radiotherapy.

Authors:  J H Hendry; S M Bentzen; R G Dale; J F Fowler; T E Wheldon; B Jones; A J Munro; N J Slevin; A G Robertson
Journal:  Clin Oncol (R Coll Radiol)       Date:  1996       Impact factor: 4.126

3.  Overall treatment time in the radiotherapy of transitional cell cancer of the bladder.

Authors:  M Kleineidam; H H Dubben
Journal:  Radiother Oncol       Date:  1992-04       Impact factor: 6.280

4.  Treatment time in bladder cancer.

Authors:  L B Marks
Journal:  Radiother Oncol       Date:  1992-04       Impact factor: 6.280

5.  A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancer.

Authors:  S Dische; M Saunders; A Barrett; A Harvey; D Gibson; M Parmar
Journal:  Radiother Oncol       Date:  1997-08       Impact factor: 6.280

6.  Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trial.

Authors:  J C Horiot; P Bontemps; W van den Bogaert; R Le Fur; D van den Weijngaert; M Bolla; J Bernier; A Lusinchi; M Stuschke; J Lopez-Torrecilla; A C Begg; M Pierart; L Collette
Journal:  Radiother Oncol       Date:  1997-08       Impact factor: 6.280

7.  Local control, TCD50 and dose-time prescription habits in radiotherapy of head and neck tumours.

Authors:  H H Dubben
Journal:  Radiother Oncol       Date:  1994-09       Impact factor: 6.280
  7 in total
  2 in total

1.  [Surgery with postoperative radiotherapy compared with primary radiotherapy in mouth and oropharyngeal carcinomas].

Authors:  S Appold; M Baumann
Journal:  Strahlenther Onkol       Date:  1999-05       Impact factor: 3.621

Review 2.  [Delays and treatment interruptions: difficulties in administering radiotherapy in an ideal time-period].

Authors:  Carmen González San Segundo; Felipe A Calvo Manuel; Juan Antonio Santos Miranda
Journal:  Clin Transl Oncol       Date:  2005-03       Impact factor: 3.405
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.